Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Levity
Levity is closed. This is a historical comparison. Read the closure and continuity update →
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · Levity: October 2026
vs
Verdict61/ 100
Grade C · #355Levity
Levity permanently closed its U.S. service in September 2026; no new or repeat subscription orders are available.
Read closure updateThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 61/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Levity still earns its place — former patients seeking closure information, subscription records, and treatment-history transfer.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results64
92
Real-world results64
97Price honesty20
97
Price honesty20
96Prescriber access77
96
Prescriber access77
88Formulary choice48
88
Formulary choice48
95Cancellation fairness92
95
Cancellation fairness92
93Member support79
93
Member support79
Price, coverage & features
| Metric | CoreAge Rx | Levity |
|---|---|---|
| Verdict Score | 94/100 | 61/100 |
| Grade | A | C |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $149/mo | Not disclosed |
| Coverage | All 50 states | Service closed September 2026 |
| Brand-name access | Compounded only | Unavailable |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Levity
What we like
- Publishes a permanent closure notice
- Says existing subscriptions were canceled automatically
- Offers treatment-history transfer assistance to sister service ZipHealth
The caveats
- No new or repeat Levity orders
- A replacement service requires a separate order and clinical review
- Old prices and treatment descriptions are historical
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Former patients seeking closure information, subscription records, and treatment-history transfer.
Read closure update Read the full Levity review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Levity does the reverse.
More on CoreAge Rx
More on Levity
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.